Early CPAP treatment for individuals with OSA may help reduce the onset of Parkinson disease and other neurodegenerative ...

Among patients with obstructive sleep apnea using CPAP, pitolisant given at 20 mg and 40 mg reduces excessive daytime sleepiness.

This review included 30 studies to analyze the potential for prolonged life in patients who use CPAP to treat obstructive sleep apnea.

Obstructive sleep apnea may increase the risk for Parkinson’s disease, but early intervention with continuous positive airway ...

Compared with placebo, pitolisant 20 and 40 mg had a greater treatment response for residual excessive daytime sleepiness in patients with OSA treated with CPAP. Pitolisant reduces residual ...

Home CPAP device maker Resmed is launching a small, disposable wearable to help diagnose cases of obstructive sleep apnea.  | ...

Medicare covers 80% of the cost for a CPAP machine and supplies if you have a specific type of sleep apnea. To get coverage for a CPAP machine, you have to show that you have sleep apnea by having a ...

Medicare covers continuous positive airway pressure (CPAP) machines when a doctor orders it. A person must have sleep apnea and meet other Medicare requirements. Medicare often covers CPAP therapy ...

A new Resmed-supported study showing sleep apnea patients on CPAP therapy live longer will further fuel a “once-in-a-generation opportunity” to increase awareness, says Carlos Nunez, ...